← Leaderboards
Margot Lazow
Research Inst Nationwide Children'S Hosp
$2,244,732
Attributed
$4,489,464
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
FDA$4,489,464 · 2
By mechanism
R01$4,489,464 · 2
Top collaborators
- Ralph Salloum2 shared
- Maryam Fouladi1 shared
Grant awards (3)
Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma$3,218,733
R01 · FY2025 · FD
Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]$485,894
R01 · FY2024 · FD · contact PI
Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]$784,837
R01 · FY2022 · FD · contact PI